Connie Montgomery: Every Patient Deserves Representation in Clinical Research
Connie Montgomery, National Member Board of Trustees Camden Coalition at Camden Coalition, shared American Society of Hematology‘s a post on LinkedIn:
“Trialport supports that all people need to be represented in clinical trials especially for those of us living with bleeding disorders and other diseases.”
American Society of Hematology shared a post on LinkedIn:
“Representation in clinical trials doesn’t improve by accident—it improves by design.
The ASH Toolkit for Clinical Trial Sponsors provides a step-by-step, practical resource to build equity into the trial life cycle from the outset.
Find concrete recommendations, examples, and curated references to help enhance access, broaden participation, and generate results that truly reflect the patients impacted by the disease or therapy.
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Jun 30, 2026, 06:01Jared Rice: Anemia of Prematurity is Not Simply an EPO Deficiency
-
Jun 30, 2026, 05:55Benjamin YQ Tan: Exploring the Heart-Brain-Thrombosis Continuum
-
Jun 30, 2026, 05:37Maxime Dely: Blood Donation – Bridging the Global Gap in Access
-
Jun 30, 2026, 05:20Jenny Amphlett: A Decade of Excellence in Anticoagulation Care
-
Jun 30, 2026, 05:16Diana Langworthy: New Episode – Solving the DOAC vs. Warfarin Mystery in Cirrhosis
-
Jun 30, 2026, 05:06Brian Haddigan: Beyond Stent Design – The Importance of Blood Compatibility
-
Jun 30, 2026, 04:47Kaihang Wang: Portal Vein Thrombosis After Pediatric Liver Transplantation
-
Jun 30, 2026, 04:12Maia Meier: Driving Change for Women and Girls with Bleeding Disorders
-
Jun 30, 2026, 03:19Wolfgang Miesbach: Weight-Bearing Lunge Test for Ankle Assessment in Haemophilia?